DeepHealth, a global leader in AI-powered health informatics and a wholly owned subsidiary of RadNet, Inc. (NASDAQ: RDNT), today unveils at ECR 2026 the industry's most comprehensive portfolio of ...
Profound Medical Corp. (NASDAQ:PROF) Q4 2025 Earnings Call Transcript March 6, 2026 Operator: Good day, and thank you for ...
Based in Paris, France, Gleamer serves over 700 customer contracts worldwide with a broad portfolio of FDA-cleared and CE-marked solutions for ...
What did these folks do to deserve to be God's favorites?
In the real-world, Pluvicto™ showed 13.5 months median PFS in chemo-naïve patients with PSMA-positive mCRPC; Real‑world evidence showed Pluvicto achieved longer PFS when init ...
The AI medical imaging market is projected to hit nearly $20 billion by 2033, growing at a 34.7% CAGR([1]) . Echocardiography alone is forecast to grow to $2.64 billion by 2030 as hospitals demand ...
Good morning, ladies and gentlemen, and thank you for joining Dr. Howard G. Berger and me today to discuss RadNet, Inc.’s fourth quarter and full year 2025 financial results. On this call, we also ...
Dr. Raza Bokhari, Exec Chairman & CEO, Interviewed by Bloomberg Open Interest Anchor Matt Miller PHILADELPHIA, PA / ACCESS Newswire / February 12, 2026 / Medicus Pharma Ltd. (NASDAQ:MDCX) (“Medicus” ...
A PSMA PET scan found more recurrent prostate cancer at low PSA levels than a standard scan, helping guide more potentially curative treatment decisions. A newer type of prostate cancer scan called 64 ...
Of all the health conditions facing men as they get older, there is no doubt that prostate cancer is the most widely discussed, emotive and challenging. It is also fairly controversial, given the ...